Formulation and Evaluation of Antibiotic Wound Healing Using Mitragyna Parvifolia: A Review

Mitragyna parvifolia is an ethnomedicinal herb with significant potential as a natural wound-healing agent, especially in the context of increasing antibiotic resistance. Traditional use of this plant in folk medicine supports its therapeutic relevance, and modern research has highlighted its antibacterial, anti-inflammatory, antioxidant, and regenerative properties. The plant's bioactive constituents’ alkaloids, flavonoids, and triterpenoids play critical roles in inhibiting bacterial growth, reducing oxidative stress, and enhancing collagen synthesis. These compounds contribute to the plant’s efficacy against Staphylococcus aureus and Pseudomonas aeruginosa, two key pathogens commonly associated with wound infections. Alkaloids, in particular, disrupt bacterial cell walls and inhibit biofilm formation, providing an effective antimicrobial mechanism. Moreover, Mitragyna parvifolia modulates inflammatory responses by regulating cytokines such as TNF-α, IL-1β, and IL-6, leading to reduced inflammation and improved macrophage activity. Its antioxidant properties prevent tissue damage and promote fibroblast proliferation, which is vital for tissue regeneration and increased tensile strength in the healing process. Various formulations, including topical ointments, hydrogels, and wound dressings, have incorporated Mitragyna extracts often synergistically with other herbs—to enhance efficacy. Preclinical studies on animal models have demonstrated promising results with improved healing rates and tissue repair. However, further clinical research is necessary to validate these findings in human subjects and establish standardized protocols for safe use. Overall, Mitragyna parvifolia represents a promising alternative in wound management, offering a natural solution to combat infections and support healing amidst the global challenge of antibiotic resistance.